Osmond Allison, Li-Chang Hector, Kirsch Richard, Divaris Dimitrios, Falck Vincent, Liu Dong Feng, Marginean Celia, Newell Ken, Parfitt Jeremy, Rudrick Brian, Sapp Heidi, Smith Sharyn, Walsh Joanna, Wasty Fasahat, Driman David K
J Clin Pathol. 2014 Sep;67(9):781-6. doi: 10.1136/jclinpath-2014-202177.
Following the introduction of colorectal cancer screening programmes throughout Canada, it became necessary to standardise the diagnosis of colorectal adenomas. Canadian guidelines for standardised reporting of adenomas were developed in 2011. The aims of the present study were (a) to assess interobserver variability in the classification of dysplasia and architecture in adenomas and (b) to determine if interobserver variability could be improved by the adoption of criteria specified in the national guidelines.
An a priori power analysis was used to determine an adequate number of cases and participants. Twelve pathologists independently classified 40 whole-slide images of adenomas according to architecture and dysplasia grade. Following a wash-out period, participants were provided with the national guidelines and asked to reclassify the study set.
At baseline, there was moderate interobserver agreement for architecture (K=0.4700; 95% CI 0.4427 to 0.4972) and dysplasia grade (K=0.5680; 95% CI 0.5299 to 0.6062). Following distribution of the guidelines, there was improved interobserver agreement in assessing architecture (K=0.5403; 95% CI 0.5133 to 0.5674)). For dysplasia grade, overall interobserver agreement remained moderate but decreased significantly (K=0.4833; 95% CI 0.4452 to 0.5215). Half of the cases contained high-grade dysplasia (HGD). Two pathologists diagnosed HGD in ≥75% of cases.
The improvement in interobserver agreement in classifying adenoma architecture suggests that national guidelines can be useful in disseminating knowledge, however, the variability in the diagnosis of HGD, even following guideline review suggests the need for ongoing knowledge-transfer exercises.
在加拿大全面推行结直肠癌筛查计划后,有必要对结直肠腺瘤的诊断进行标准化。2011年制定了加拿大腺瘤标准化报告指南。本研究的目的是:(a)评估腺瘤发育异常和结构分类中的观察者间变异性;(b)确定采用国家指南中规定的标准是否能改善观察者间变异性。
采用先验功效分析来确定足够数量的病例和参与者。12名病理学家根据结构和发育异常等级对40张腺瘤全切片图像进行独立分类。在洗脱期后,向参与者提供国家指南,并要求他们对研究集重新分类。
在基线时,观察者间在结构分类方面存在中度一致性(K=0.4700;95%CI 0.4427至0.4972),在发育异常等级分类方面存在中度一致性(K=0.5680;95%CI 0.5299至0.6062)。在分发指南后,观察者间在评估结构方面的一致性有所改善(K=0.5403;95%CI 0.5133至0.5674)。对于发育异常等级,观察者间总体一致性仍为中度,但显著下降(K=0.4833;95%CI 0.4452至0.5215)。一半的病例包含高级别发育异常(HGD)。两名病理学家在≥75%的病例中诊断出HGD。
腺瘤结构分类中观察者间一致性的提高表明国家指南在传播知识方面可能有用,然而,即使在指南审查后,HGD诊断的变异性仍表明需要持续进行知识传授活动。